Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PCTL will make their movement when results start to filter out in the upcoming financial reports especially the Q1 and definitely the Q2 report.
PCTL is in a great position to disrupt the market share of contracts for Infection Control Systems with Healthcare and other industries.
Why did they focus on Healthcare first?
Hospital Disinfectant Products Market to Expand at Growth Rate of ~ 5.3% CAGR from 2018 to 2026 to Reach US$ 17.1 Billion through 2026:
https://www.prnewswire.com/news-releases/hospital-disinfectant-products-market-to-expand-at-growth-rate-of--5-3-cagr-from-2018-to-2026-to-reach-us-17-1-bn-through-2026-transparency-market-research-300999388.html
PCTL is a small player and is limited by their size and available financing. I'm sure they are well aware of this and are aggressively working to find a deep pocket investor(s) or possible partnership.
PCTL has the best solution to a multi-billion dollar problem will it be an investor or a partnership to help solve it.
Maybe it will be one these major players:
Key companies in the Hospital Disinfectant Products market include The Procter & Gamble Company, Colgate-Palmolive Company, Baxter International Inc, Kimberly-Clark Corporation, Getinge AB, and Georgia-Pacific LLC
Multi-Billion dollar problem:
Hospitals & Healthcare:
The Problem:
Preventing Microbial Infections
Many billions of dollars a year are spent by individuals, organizations and the health care system to treat people who get infectious diseases caused by microbes including bacteria, viruses and fungi. With the advent of adaptive and ever more dangerous microorganisms called “super bugs”, the danger of acquiring life-threatening infections is real and growing. This danger affects everyone anytime they are in space where people gather, any microbe contaminating that space is a possible source of infection. With American’s spending 20 or more hours a day indoors, much of it in spaces that are not cleaned and sanitized/ disinfected properly, the threat of infection is constant, growing and dangerous, particularly to our vulnerable populations of the very young, elderly and infirm.
Infectious diseases were associated with an economic burden of over $120 billion in the U.S. in 2014. Antibiotic resistant infections cost Americans $20 billion in direct medical costs and $35 billion in lost productivity in 2014. A particularly acute problem is Hospital Acquired Infections (HAIs) which are increasingly hard to kill or treat effectively. As a result, doctors struggle to contain, fight and cure increasingly antibiotic resistant infections such as MRSA, and C. Diff. The more antibiotics, medicines, pesticides and disinfectants are used to kill them, the quicker the microorganisms adapt, becoming ever stronger and more drug-resistant. Researchers estimate that, if the U.S. could reduce the number of hospital-acquired infections by 20%, healthcare providers would save nearly $7 billion per year. Insurance companies are beginning to deny coverage for treatment of HAIs, forcing hospitals to self-insure. This will create an immense financial and risk-management burden on hospitals, long-term medical, rehabilitation and assisted living facilities.
https://pctcorphealth.com/
The Solution:
Overcoming the problem of microbial contamination and infectious disease can be straightforward. It requires proper products, equipment, protocols, education, and training for comprehensive and reliable cleaning, sanitizing and disinfecting solutions. PCT Corp. offers these with its comprehensive “Green Cleaning” and Infection Control Systems. Infectious microbes cannot develop resistance to the cleaning and sanitizing products PCT Corp. uses and they are much less toxic to humans or pets than traditional agents such as bleach and ammonia.
The products are used through a commercially-ready, patented, integrated product and technology solution for total facility cleaning and sanitizing. This system and solution, The PCT Annihilyzer® Infection Control System, was specifically designed for use in hospitals, assisted-living and nursing homes and other large facilities. In various configurations, the solution system can be deployed in urgent care centers, medical, dental and veterinary practices and other health care facilities. A complete and custom turn-key cleaning, sanitizing and disinfection program solution can be provided to each facility. It is also adaptable to deployment in schools, prisons, hotels and many other facilities.
PCT has launched a major marketing and sales effort in the hospital facilities market and The PCT Annihilyzer® System has now been deployed in several hospitals in the eastern U.S.
Learn more about The Annihilyzer® System
https://www.para-con.com/products.php#annihilyzer
Agriculture
In the agriculture world, through USDA grants and multiple studies by universities around the world, Hypochlorous acid solutions have been tested and proven effective against yield-reducing crop pathogens in post-harvest applications to include sanitizing at point of harvest, point of packing and points of sale.
We are hoping to help stop these crop-devastating pathogens with our hypochlorous solutions that are known to be environmentally responsible and designed to improve and maintain crop yields, to produce a healthier overall harvest.
Oil and Gas
Waste Water Treatment
Our system helps to decontaminate “frac” water for reuse in the fracking process, saving the industry millions of dollars and preserving the world’s water supply. Some of the many benefits of our system/process include: Elimination of highly toxic chemicals currently used for decontamination, reduced negative environmental impact, reduced recovery costs and potentially opening new areas for oil and gas retrieval.
Turning “Sour” Crude Oil to “Sweet"
In other areas in the gas and oil industry that presents a challenge is in treating existing wells for the presence of H2S of hydrogen sulfide. H2S is a large and growing problem in the industry, due to its continued introduction of bacteria in the fracking process. H2S causes increased production costs. Our solutions reduce those costs and reduce the environmental impact.
Other
Hotel and Tourism
Similar to the healthcare environment, the hotel and tourism industry (i.e resorts, airports, cruise ships, etc.) are subject to communicable diseases. In the healthcare market, they are referred to as Hospital-Acquired Infections/Healthcare-Associated Infections (HAIs) and in the hotel and tourism industry, they are known as Community-Acquired Infections. With as many different people traveling through these areas, from all sorts of countries and carrying various types of ailments or pathogens with them, consider the potential for an uncontrollable spread of these germs.
Outbreaks are typically caused by lack of proper processes and/or a failing product. Our ECA technology is designed to help anyone in the industry to get a grip on the issue and succeed at their main goal: providing an awesome experience for their guests.
Food Service/Production
Our sanitizer strength solution meets the requirement of the FDA and USDA, to be a non-rinse sanitizing agent. In the world of dealing with food, why not use a product that actually kills food-borne pathogens - without containing any toxic chemicals that would harm the quality of the product?
Whether you’re dealing with meat, poultry or just need to maintain a facility’s defense against Salmonella/E. coli, contact us about using our solutions.
Learn more at Survivalyte.com
http://survivalyte.com
Whole-room cleaning company sees dramatic rise in clients
https://cleanroomtechnology.com/news/article_page/Wholeroom_cleaning_company_sees_dramatic_rise_in_clients/163321
PCT has installed its Annihilyzer System at another New York City hospital. Annihilyzer Infection Control System is a whole-room cleaning and disinfecting system for hospital and healthcare facilities.
The CEO explains that the company has developed cleaning and disinfecting protocols, utilised with its patented RFID material tracking system, for the proper use of solutions and electrostatic applicators being used in every area of the facility.
“As a result of the capabilities and benefits of our products, many companies and municipalities across a variety of industries and geographic locations are engaging in intense discussions with PCT. We believe that this hospital will be the first of many installations during the coming months,” Grieco explained.
Grieco explained on the Stock Day Podcast that the company believes it has developed a unique type of disinfectant system based on hypochlorous acid. “The core technology, which is hypochlorous acid, has been around for many years, but it’s had what the market has perceived as drawbacks - not because of its efficacy, but because it’s not a product that lends itself to storage long-term.”
Greico emphasised that their disinfecting system has demonstrated its ability to destroy various bacteria and viruses, without the noxious and other adverse side effects found with conventional chlorine solutions.
Grieco added: “All of our hospital customers using our infection control system and disinfectant are utilising the systems as a front-line defence throughout their facilities, including in all public area such as restrooms, lobbies, waiting rooms, elevators, corridors, cafeterias, etc. all throughout the day and night and in the presence of patients, staff and visitors.”
An article from March 2020, stated: “We expect to grow at the rate of two hospitals a month for the first part of this year and then to double that for the second half of the year. We have been dubbed a disruptive technology for hospitals. However, it does not have to be limited to hospitals. There are certainly other markets, such as assisted living facilities, schools, even companies and factories that could use this system to reduce sickness.”
PCTL received their extension as any other company when they filed an 8K why they needed one. It was basically automatic however an 8K must have been filed by a certain date.
PCTL shareholders yesterday is gone tomorrow is not promised today is a present so take advantage!
What drives up a stock price results!!!
PCTL 10K results will be less than desirable that is already known.
What is partially known is that PCTL is in a position on a cash flow basis to cover their burn rate.
The unknown is just how much cash is flowing due to increase sales of fluids and the unprecedented demand for Infection Control Systems.
The subsequent event section of the 10K may reveal some of these unknowns.
The demand for Infection Controls Systems is not being met worldwide.
Profits for all who can provide systems!!!
PCTL PCTL PCTL
By the Numbers
271,000 Infection Controls Systems sold yearly!!!
Bids are being requested in the thousands!!!
Growth Rates Through The ROOF 400%...600%...2000%!!!
In Coronavirus Fight, Robots Report For Disinfection Duty
https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/
You can use the handheld device with people present as that is well documented.
While using the whole room robot I don't believe patients are present.
PCTL is cleared for take off!!!
“Your time is limited, so don’t waste it living someone else’s life. Don’t be trapped by dogma – which is living with the results of other people’s thinking. Don’t let the noise of others’ opinions drown out your own inner voice. And most important, have the courage to follow your heart and intuition.” Steve Jobs
PCTL USA
From the March 9, 2020 CEOCFO Magazine Interview:
CEOCFO: There are so many new ideas and services for hospitals to consider. What is the key to getting a foot in the door?
Mr. Grieco: I would love to have the answer to this question! I have told people that I think I would rather sell a jet plane to the US government than try to get a product into a hospital again! It is very difficult, especially for a small company! There have been some people, and this is just gratifying on a personal level, who have recognized what we have accomplished. I have had people say that they never would have believed that we would have ever gotten into hospitals. The mere fact that the next hospital we will be going into was one of the ones that approached us is a major accomplishment, and I think you are going to be seeing more and more of that.
https://www.para-con.com/images/docs/PCTL03-10-20.pdf
Just how many hospitals or other organizations contacted PCTL?
When did the surge in calls start.
So from at least early March 2020 the phone is ringing off the hook at PCTL and by April 21, 2020 the company determines the need to produce at least 25 Annihilyzer Systems a month:
[color=green][/color]“We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” [/color]he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
That gives them less than 3 months to get production up to produce 25 systems a month.
The BIG QUESTION is who are all these systems for?
The Company currently has three new distributors and is expecting to add an additional three to four distributors within the next ten days. "Each one of these distributors is already in business," said Grieco. "What they are doing is shifting from using the harsh chemicals to using our product in their businesses," he continued, adding that hospitals have also expanded their use of the product in their facilities.
https://www.para-con.com/images/docs/PCTL04-21-20.pdf
PCTL UK:
In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT’s unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the U.K. will also be introduced to PCT’s technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021. This system is expected to enter clinical service early in May once the final series of biological tests of the PCT hospital disinfectant solution have been completed. Results of these tests have so far demonstrated that the PCT disinfectant has met or exceeded its ability to kill the range of pathogens previously achieved during EPA tests in the United States.
https://www.para-con.com/images/docs/PCTL04-16-20.pdf
PCTL China:
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
Did somebody say competition?
The demand for Infection Control Systems is at an all time HIGH!!!
Ride the wave
Roll Baby Roll
By the Numbers
271,000 Infection Controls Systems sold yearly!!!
Bids are being requested in the thousands!!!
Growth Rates Through The ROOF 400%...600%...2000%!!!
The need for Infection Control Systems because of the pandemic is record breaking.
Never in the course of human history has so many wanted so much that companies just can’t keep up.
The pandemic has caused an epidemic in not only health care but everywhere.
These systems are needed and wanted all over the world:
PCTL tabled a MOU with China to take care of USA first:
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
Xenen a private company Sees Surge In Orders As COVID-19 Pandemic Escalates
Xenex is being asked for bids on quantities of robots “in the thousands,”
The recent increase in business follows a year in which Xenex turned the corner to profitability, according to Miller. Revenue percentage growth was up about 20 percent in 2019, but Miller projects growth will be anywhere from 400 to 600 percent in 2020.
I wonder what PCTL growth will be???
In Coronavirus Fight, Robots Report For Disinfection Duty
https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/
Large-scale coronavirus testing continues to lag and a vaccine could be at least one year away. But in the battle against world pandemic a rapidly expanding brigade of robots is answering an urgent call of duty: surface disinfection.
They're rolling in by the hundreds and not just into hospitals and nursing homes but across a wide spectrum of public spaces, including government buildings, offices, hotels, airports and universities. Administrators of all stripes, desperate to keep people safe, are looking to a global robotics industry that has been quick to respond.
Denmark's UVD Robots, a leader in fully autonomous ultraviolet-light-disinfection robots, shipped hundreds of them to China in February and hundreds more throughout Europe in March. A much smaller number have arrived in the U.S. but several hundred more are on the way, said UVD Robots' CEO Per Juul Nielsen, speaking by telephone April 15.
"Hospitals around the world are waking up to autonomous disinfection," Nielsen said. "We can't build these robots fast enough.
"Healthcare-sector suppliers like UVD, Xenex and others still are a long way from being able to meet exploding global demand for automated disinfection solutions but it's not just specialized service robots riding into battle.
Human-friendly industrial robots, also known as collaborative robots, are being shifted away from tasks, such as machine tending and warehouse rack-stacking, and redeployed in the war on coronavirus.
The market for service robots in general has been growing. Some 271,000 of these types of robots were sold globally last year, according to data from the International Federation of Robotics. That's an increase of 61% over 2018.
Entering this year, UVD's view was that more healthcare institutions were going to want their robots owing to something else starting to spread — greater awareness about the dangers of healthcare associated infections.
Put another way, when a three-figure order from China came in February, Nielsen explained, it meant the company had nearly sold more robots that single day than it had during its full first year of commercial viability.
In the Middle East, where decision making is more centralized relative to Europe and the U.S., "some countries’ leaders have just said, ‘we need 100 of these robots,’" said Claus Risager, co-founder and CEO of Blue Ocean Robotics, speaking to The Robot Report.
Then came a targeted marketing campaign, moving from one regional healthcare sector to the next, in Scandinavian countries and eventually throughout Europe. Robot sales were steadily rising in 2019. At the end of last year, UVD projected an ambitious 2020 growth rate target: 400%.
"We already hit five times that," Nielsen said.
“We’re now seeing how mobile robots can be deployed to safeguard people, which, hopefully is changing negative perceptions some people have about robots,” said Jeff Burnstein, A3’s President. “What these applications for disinfecting, protecting hospital personnel, and related tasks illustrate is that robotics is an important technology to assist people, not replace them.”
There is a demand for Infection Control Systems worldwide and the industry can't keep up with demand.
PCTL is in a great position to acquire a deep pocket investor or as Gary Greico said it "angel funder". Traditional funding or a possible buyout are not out of the question either.
Therefore, yes! We are certainly looking for funding now; I guess the correct term would be an angel funder, from this point. Someone who understands what we do, see its impact to the healthcare system of this country, see its impact to a company that can deliver a solution to that and is willing to commit three and one half to five million dollars to that process.
Business has been changing at a rapid pace and PCTL is guaranteed money in the bank with orders in hand.
One last thing to take notice of that Gary said:
“We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
He did not say 25 systems a month he said at least 25 systems a month.
Me thinks it is going to be more many many more....
The sky is the limit.
Paradigm intends to deploy its on-site production equipment under service contracts, charging an installation and set-up fee followed by monthly contract fees (some pricing models may include, or be based on, a price per gallon of product used). The equipment will be deployed and maintained through Paradigm-licensed commercial services companies that provide the on-site support as required. The product generators and other components of the on-site systems will be monitored remotely by a contracting company which is highly experienced and expert in remote monitoring and response systems. The precise nature of any functional problems that may occur with any of the system’s components will be automatically communicated via the internet to the monitoring and control center. The problems are then resolved through a three-tiered problem response system: first by remote access to the computerized system controls, second by an on-site technician call, and third through a “rapid replacement” program. If problems are not resolved by the first or second tier responses, in the tier three rapid replacement response, Paradigm would overnight ship replacement parts or, if necessary a complete kiosk or system and have the defective unit returned for repair.
There is a demand for Infection Control Systems worldwide and the industry can't keep up with demand.
PCTL is in a great position to acquire a deep pocket investor or as Gary Greico said it "angel funder". Traditional funding or a possible buyout are not out of the question either.
Therefore, yes! We are certainly looking for funding now; I guess the correct term would be an angel funder, from this point. Someone who understands what we do, see its impact to the healthcare system of this country, see its impact to a company that can deliver a solution to that and is willing to commit three and one half to five million dollars to that process.
Business has been changing at a rapid pace and PCTL is guaranteed money in the bank with orders in hand.
One last thing to take notice of that Gary said:
“We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
He did not say 25 systems a month he said at least 25 systems a month.
Me thinks it is going to be more many many more....
The sky is the limit.
PCTL USA
From the March 9, 2020 CEOCFO Magazine Interview:
CEOCFO: There are so many new ideas and services for hospitals to consider. What is the key to getting a foot in the door?
Mr. Grieco: I would love to have the answer to this question! I have told people that I think I would rather sell a jet plane to the US government than try to get a product into a hospital again! It is very difficult, especially for a small company! There have been some people, and this is just gratifying on a personal level, who have recognized what we have accomplished. I have had people say that they never would have believed that we would have ever gotten into hospitals. The mere fact that the next hospital we will be going into was one of the ones that approached us is a major accomplishment, and I think you are going to be seeing more and more of that.
https://www.para-con.com/images/docs/PCTL03-10-20.pdf
Just how many hospitals or other organizations contacted PCTL?
When did the surge in calls start.
So from at least early March 2020 the phone is ringing off the hook at PCTL and by April 21, 2020 the company determines the need to produce at least 25 Annihilyzer Systems a month:
“We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
That gives them less than 3 months to get production up to produce 25 systems a month.
The BIG QUESTION is who are all these systems for?
The Company currently has three new distributors and is expecting to add an additional three to four distributors within the next ten days. "Each one of these distributors is already in business," said Grieco. "What they are doing is shifting from using the harsh chemicals to using our product in their businesses," he continued, adding that hospitals have also expanded their use of the product in their facilities.
https://www.para-con.com/images/docs/PCTL04-21-20.pdf
PCTL UK
In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT’s unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the U.K. will also be introduced to PCT’s technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.
steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.This system is expected to enter clinical service early in May once the final series of biological tests of the PCT hospital disinfectant solution have been completed. Results of these tests have so far demonstrated that the PCT disinfectant has met or exceeded its ability to kill the range of pathogens previously achieved during EPA tests in the United States.
https://www.para-con.com/images/docs/PCTL04-16-20.pdf
PCTL China:
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
The demand for Infection Control Systems is at an all time HIGH!!!
Ride the wave
Roll Baby Roll
By the Numbers
271,000 Infection Controls Systems sold yearly!!!
Bids are being requested in the thousands!!!
Growth Rates Through The ROOF 400%...600%...2000%!!!
The need for Infection Control Systems because of the pandemic is record breaking.
Never in the course of human history has so many wanted so much that companies just can’t keep up.
The pandemic has caused an epidemic in not only health care but everywhere.
These systems are needed and wanted all over the world:
PCTL tabled a MOU with China to take care of USA first:
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
Xenen a private company Sees Surge In Orders As COVID-19 Pandemic Escalates
Xenex is being asked for bids on quantities of robots “in the thousands,”
The recent increase in business follows a year in which Xenex turned the corner to profitability, according to Miller. Revenue percentage growth was up about 20 percent in 2019, but Miller projects growth will be anywhere from 400 to 600 percent in 2020.
I wonder what PCTL growth will be???
In Coronavirus Fight, Robots Report For Disinfection Duty
https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/
Large-scale coronavirus testing continues to lag and a vaccine could be at least one year away. But in the battle against world pandemic a rapidly expanding brigade of robots is answering an urgent call of duty: surface disinfection.
They're rolling in by the hundreds and not just into hospitals and nursing homes but across a wide spectrum of public spaces, including government buildings, offices, hotels, airports and universities. Administrators of all stripes, desperate to keep people safe, are looking to a global robotics industry that has been quick to respond.
Denmark's UVD Robots, a leader in fully autonomous ultraviolet-light-disinfection robots, shipped hundreds of them to China in February and hundreds more throughout Europe in March. A much smaller number have arrived in the U.S. but several hundred more are on the way, said UVD Robots' CEO Per Juul Nielsen, speaking by telephone April 15.
"Hospitals around the world are waking up to autonomous disinfection," Nielsen said. "We can't build these robots fast enough.
"Healthcare-sector suppliers like UVD, Xenex and others still are a long way from being able to meet exploding global demand for automated disinfection solutions but it's not just specialized service robots riding into battle.
Human-friendly industrial robots, also known as collaborative robots, are being shifted away from tasks, such as machine tending and warehouse rack-stacking, and redeployed in the war on coronavirus.
The market for service robots in general has been growing. Some 271,000 of these types of robots were sold globally last year, according to data from the International Federation of Robotics. That's an increase of 61% over 2018.
Entering this year, UVD's view was that more healthcare institutions were going to want their robots owing to something else starting to spread — greater awareness about the dangers of healthcare associated infections.
Put another way, when a three-figure order from China came in February, Nielsen explained, it meant the company had nearly sold more robots that single day than it had during its full first year of commercial viability.
In the Middle East, where decision making is more centralized relative to Europe and the U.S., "some countries’ leaders have just said, ‘we need 100 of these robots,’" said Claus Risager, co-founder and CEO of Blue Ocean Robotics, speaking to The Robot Report.
Then came a targeted marketing campaign, moving from one regional healthcare sector to the next, in Scandinavian countries and eventually throughout Europe. Robot sales were steadily rising in 2019. At the end of last year, UVD projected an ambitious 2020 growth rate target: 400%.
"We already hit five times that," Nielsen said.
“We’re now seeing how mobile robots can be deployed to safeguard people, which, hopefully is changing negative perceptions some people have about robots,” said Jeff Burnstein, A3’s President. “What these applications for disinfecting, protecting hospital personnel, and related tasks illustrate is that robotics is an important technology to assist people, not replace them.”
SEC reporting rules release NO. 34-88465 under Section 36 for DUMMIES:
The SEC’s Division of Corporation Finance (CorpFin) updated staff’s interpretive guidance to better explain recent regulatory relief provided to public companies amid the COVID-19 pandemic.
The staff document is called Compliance & Disclosure Interpretations: [Securities] Exchange Act [of 1934] Rules.
CorpFin updated Compliance & Disclosure Interpretations (C&DIs) on March 31, 2020, and it explains the temporary relief provided in Release No. 34-88465, Order Under Section 36 of the Securities Exchange Act of 1934 Modifying Exemptions from the Reporting and Proxy Delivery Requirements for Public Companies.
That release, issued on March 25, superseded a previous order—March 4—in Release No. 34-88318, Order Under Section 36 of the Securities Exchange Act of 1934 Granting Exemptions from Specified Provisions of the Exchange Act and Certain Rules Thereunder. (See SEC Extends Previous Reporting Relief Amid COVID-19 Challenges, in the March 26, 2020, edition of Accounting & Compliance Alert.
In Release No. 34-88465, the SEC said it is extending the filing periods once again for certain public company reports required to be filed under the federal securities laws. This comes as authorities have limited people’s gatherings and travel to combat the spread of the novel coronavirus. And companies have also been having difficulty figuring out the information that should be put in their regulatory filings about the impact of the health and economic crises without running afoul of regulators.
The new time period for the relief is for reports due from March 1 to July 1, and companies get 45 extra days.
In the updated C&DIs, one question says that a company expects that it will not be able to file a certain report on a timely basis without incurring an unreasonable effort or expense, and the company does not know whether it will be able to file the report within the applicable period. Thus, the company asked whether it should instead furnish a report on Form 8-K or 6-K as applicable relying on Release No. 34-88465.
“Yes. As a condition to its use, the COVID-19 Order requires, among other things, that the registrant furnish certain specified statements by the later of March 16, 2020 or the original due date of the required report. If the registrant only files a Form 12b-25 by the original due date of the required report, it will have not met the condition of the COVID-19 Order to provide the statements called for by the original filing deadline on a furnished Form 8-K or Form 6-K,” the staff guidance responds. “Unless this condition is met, the 45-day relief period provided in COVID-19 Order will not be available.”
Companies use Form 8-K to let investors know about specific events that may be important to them, for example, to let shareholders know of bankruptcy or sudden halt to productions. Foreign companies that register with the SEC use Form 6-K for financial reports.
CorpFin staff added that companies that cannot use the temporary relief provided in the order should contact staff to discuss “collateral consequences of late filings.”
In Coronavirus Fight, Robots Report For Disinfection Duty
https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/
Large-scale coronavirus testing continues to lag and a vaccine could be at least one year away. But in the battle against world pandemic a rapidly expanding brigade of robots is answering an urgent call of duty: surface disinfection.
They're rolling in by the hundreds and not just into hospitals and nursing homes but across a wide spectrum of public spaces, including government buildings, offices, hotels, airports and universities. Administrators of all stripes, desperate to keep people safe, are looking to a global robotics industry that has been quick to respond.
Denmark's UVD Robots, a leader in fully autonomous ultraviolet-light-disinfection robots, shipped hundreds of them to China in February and hundreds more throughout Europe in March. A much smaller number have arrived in the U.S. but several hundred more are on the way, said UVD Robots' CEO Per Juul Nielsen, speaking by telephone April 15.
"Hospitals around the world are waking up to autonomous disinfection," Nielsen said. "We can't build these robots fast enough."
Healthcare-sector suppliers like UVD, Xenex and others still are a long way from being able to meet exploding global demand for automated disinfection solutions but it's not just specialized service robots riding into battle.
Human-friendly industrial robots, also known as collaborative robots, are being shifted away from tasks, such as machine tending and warehouse rack-stacking, and redeployed in the war on coronavirus.
"In the mobile [robot] space, there are a huge amount of inbound [inquiries] surrounding [UV-light and chemical] disinfection," said Melonee Wise, CEO of Fetch Robotics in San Jose, Calif.
Wise, in comments made during a recent webcast held by the Association for Advancing Automation (A3), said that her staff is fielding up to 20 leads a day, from representatives at companies and institutions, all wanting to know: "can you autonomously disinfect my facility?"
Earlier this month, a team of researchers at the USC Viterbi Center for Advanced Manufacturing, working intensely (while social distancing) for weeks, were able to retool a semi-autonomous mobile manipulator, a type of robot commonly used in small factories and warehouses.
Their resulting modification, the “ADAMMS-UV” robot, comprises three different hardware components. For a mobile base, the team used an Inspectorbots’ SuperMega Bot; mounted on that base is the UR5 arm from Universal Robots; on the arm, a Robotiq two-fingered gripper.
Then they fitted their creation with UV-light wands, augmented vision guidance and new software so it could learn detailed, dangerous disinfection tasks in places such as dorm rooms and offices, environments that are going to be difficult to clean thoroughly using purely autonomous mobile disinfection robots that do not have arms.
The USC team’s robot is paired with a human operator working remotely, making high-level decisions, such as pause, open that drawer.
"As a society we have a tremendous amount of work ahead of us to disinfect public spaces," said Satyandra Gupta, the director of the USC Center for Advanced Manufacturing and the Smith International Professor of Mechanical Engineering and Computer Science.
Gupta's group was responsible for making sure the robot works.
"This means we’ll need to apply all kinds of mobile robots - a lot of them," Gupta said.
In recent weeks, Xenex has seen a surge in sales coming from their usual customers, such as hospitals and urgent care facilities, as well as a wide variety of office buildings, companies, government agencies and hotels.
In recent weeks, Xenex has seen a surge in sales coming from their usual customers, such as hospitals and urgent care facilities, as well as a wide variety of office buildings, companies, government agencies and hotels.
During January, as the virus spread around China, Xenex began ramping up production. Over a few days in February, they shipped dozens of robots to Italy.
“At any other time, we celebrate these wins," Irene Hahn, VP-Sales, said in an email to colleagues after the big Italian order came in. "However, in light of what is happening, this one is different … we are absolutely humbled.”
All told, Xenex's LightStrike robots have been deployed in more than 500 healthcare facilities worldwide.
Similarly, there’s been a surge of interest in competitor UVD Robots, capping a four-year mission to build, test and come to market with an autonomous mobile robot that can enter a room then safely disinfect it with UV-light.
UVD is owned by privately held Blue Ocean Robotics, known for its Robot Venture Factory in the Southern Denmark city of Odense.
Specializing in conceiving and commercializing problem-solving service robots, Blue Ocean finances the development phase, moving each viable robot line into its own subsidiary-venture company. Other portfolio holdings include GoBe Robots, a mobile telepresence robot for communication, social inclusion and CO2 reductions and PTR Robots, a mobile robot for safe patient handling and rehabilitation.
The market for service robots in general has been growing. Some 271,000 of these types of robots were sold globally last year, according to data from the International Federation of Robotics. That's an increase of 61% over 2018.
Entering this year, UVD's view was that more healthcare institutions were going to want their robots owing to something else starting to spread — greater awareness about the dangers of healthcare associated infections.
The UVD robot's HAI-eradicating effectiveness — for example, being able to reduce an ICU room's bacteria level by 80% — was clinically verified in 2018 at Odense University Hospital where units went through extensive tests involving all kinds of bacteria, fungi, and viruses, as well as tests relating to time of exposure, angles, shadowing effects, and reflections.
The UVD robot's HAI-eradicating effectiveness — for example, being able to reduce an ICU room's bacteria level by 80% — was clinically verified in 2018 at Odense University Hospital where units went through extensive tests involving all kinds of bacteria, fungi, and viruses, as well as tests relating to time of exposure, angles, shadowing effects, and reflections.
Then came a targeted marketing campaign, moving from one regional healthcare sector to the next, in Scandinavian countries and eventually throughout Europe. Robot sales were steadily rising in 2019. At the end of last year, UVD projected an ambitious 2020 growth rate target: 400%.
"We already hit five times that," Nielsen said.
Put another way, when a three-figure order from China came in February, Nielsen explained, it meant the company had nearly sold more robots that single day than it had during its full first year of commercial viability.
In the Middle East, where decision making is more centralized relative to Europe and the U.S., "some countries’ leaders have just said, ‘we need 100 of these robots,’" said Claus Risager, co-founder and CEO of Blue Ocean Robotics, speaking to The Robot Report.
Imitators need to be scrutinized, Risager cautioned. “So many people are trying to copy the UVD robots,” he said. "There’s more to our product than putting light bulbs on a robot."
“We’re now seeing how mobile robots can be deployed to safeguard people, which, hopefully is changing negative perceptions some people have about robots,” said Jeff Burnstein, A3’s President. “What these applications for disinfecting, protecting hospital personnel, and related tasks illustrate is that robotics is an important technology to assist people, not replace them.”
Prior to the pandemic, USC researchers had already created the Agile Dexterous Autonomous Mobile Manipulation System, or ADAMMS, to do cutting-edge machine tending tasks such as moving or loading parts or materials. In a large industrial setting, such tasks involve conveyor belts, autonomous guided vehicles and large robotic arms, overkill and too expensive for smaller manufacturers that still rely mainly on humans. The original ADAMMS was designed to be semi-autonomous with a video-game style interface so a human operator could give the bot high-level instructions, as needed.
Modifying ADAMMS to do a wider array of COVID-19 disinfection tasks, the USC team earlier this month rolled out ADAMMS-UV, which resembles a mini-airline-beverage cart on four sturdy tricycle-sized tires. It’s able to drive itself near objects of interest and manipulate them, so as to reach spaces that can't be treated by UV sources mounted on a mobile base. A depth camera is affixed to the wrist of the robotic arm and there are multiple cameras on the sides of the base, providing situational awareness for the operator who can take control at any time.
"Keeping a human in the loop is required," said Hyojeong Kim, a student on the team. "In a cluttered area, a robot might need some guidance."
UV light is a proven disinfectant. Coronavirus on a surface can be killed when exposed to UV light of sufficient intensity for an appropriate amount of time. The robot can hold the UV wand over a surface and move it at the right speed, meticulously, consistently, without any mistakes, in a manner that a human would find pretty much impossible.
Prior to the pandemic, USC researchers had already created the Agile Dexterous Autonomous Mobile Manipulation System, or ADAMMS, to do cutting-edge machine tending tasks such as moving or loading parts or materials. In a large industrial setting, such tasks involve conveyor belts, autonomous guided vehicles and large robotic arms, overkill and too expensive for smaller manufacturers that still rely mainly on humans. The original ADAMMS was designed to be semi-autonomous with a video-game style interface so a human operator could give the bot high-level instructions, as needed.
Modifying ADAMMS to do a wider array of COVID-19 disinfection tasks, the USC team earlier this month rolled out ADAMMS-UV, which resembles a mini-airline-beverage cart on four sturdy tricycle-sized tires. It’s able to drive itself near objects of interest and manipulate them, so as to reach spaces that can't be treated by UV sources mounted on a mobile base. A depth camera is affixed to the wrist of the robotic arm and there are multiple cameras on the sides of the base, providing situational awareness for the operator who can take control at any time.
The need for Infection Control Systems because of the pandemic is record breaking.
Never in the course of human history has so many wanted so much that companies just can’t keep up.
The pandemic has caused an epidemic in not only health care but everywhere.
These systems are needed and wanted all over the world:
PCTL tabled a MOU with China to take care of USA first:
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
Xenen a private company Sees Surge In Orders As COVID-19 Pandemic Escalate
Xenex is being asked for bids on quantities of robots “in the thousands,”
The recent increase in business follows a year in which Xenex turned the corner to profitability, according to Miller. Revenue percentage growth was up about 20 percent in 2019, but Miller projects growth will be anywhere from 400 to 600 percent in 2020.
I wonder what PCTL growth will be???
What is the market for robots?
In Coronavirus Fight, Robots Report For Disinfection Duty
The market for service robots in general has been growing. Some 271,000 of these types of robots were sold globally last year, according to data from the International Federation of Robotics. That's an increase of 61% over 2018.
https://www.forbes.com/sites/richblake1/2020/04/17/in-covid-19-fight-robots-report-for-disinfection-duty/
5 Top Robotic Disinfectant Solutions Impacting Public Safety During The Coronavirus Pandemic
As the coronavirus pandemic intensifies, stakeholders are racing against time to maintain public health and safety. We analyzed 25 robotic disinfection startups & emerging companies working on these solutions and showcase UVD Robots, Xenex Disinfection Services, Nevoa, Neolix, and XAG in this article!
I wonder if PCTL was one of the 25.
https://www.startus-insights.com/innovators-guide/5-top-robotic-disinfectant-solutions-impacting-public-safety-during-the-coronavirus-pandemic/
To prevent the spread of the coronavirus inside hospitals and other public places, it is essential to keep surfaces disinfected. But the manual cleaning process is dangerous, considering the possibility of getting infected. That’s why it is a perfect task for autonomous disinfection robots. Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups working on public safety solutions that ensure safety for medical and health workers and for the larger public. This time, we take a look at top robotic disinfectant solutions.
We use a data-driven startup scouting approach to identify the most relevant solutions globally. The Global Startup Heat Map below highlights 5 interesting examples out of 25 relevant solutions. We analyzed technology-driven solutions that ensure public safety and health for millions of people around the world.? UVD Robots, Xenex Disinfection Services, Nevoa, Neolix, and XAG develop 5 top solutions to watch out for!
Nevoa – Room Disinfecting System
Besides non-chemical disinfection methods like ultraviolet (UV) light, there are other ways to rapidly kill bacteria – by using chemical disinfectants. These disinfectants kill bacteria by damaging their proteins or by interfering with their metabolism. The choice and intensity of a disinfectant depend on its requirements – some have a wide-spectrum, that is, they kill many different types of microorganisms while others kill a narrower range of disease-causing organisms.
Scottish company Nevoa develops robotic disinfectant solutions that demonstrate high effectiveness against SARS-CoV-2, for example. Their no-touch hospital disinfection robot, Nimbus, utilizes a hypochlorous acid solution for disinfecting rooms and surfaces. Nimbus atomizes their microburst cleaning solution, an EPA-registered hospital-grade disinfectant, and completely removes its disinfectant cloud after completing the cleaning process.
Xenex Disinfection Services – Xenon Light-Based Disinfection System
Most UV light disinfection devices use mercury gas bulbs as a light source with an effective wavelength of 254?nm. The ultraviolet radiation emitted by low-pressure mercury bulbs is delivered in a continuous stream that gradually accumulates to microorganisms lethal doses. Pulsed xenon ultraviolet (PX-UV) is an alternative to traditional UV methods offering high-intensity pulse germicidal UV. It is emitted in short, high-intensity pulses, possibly requiring a shorter duration of exposure, to achieve lethal doses. PX-UV light potentially possesses greater efficacy than other forms of UV, such as mercury UV, because of its broad-spectrum and greater intensity.
The US-based company Xenex Disinfection Services creates LightStrike robots that use pulsed xenon light to disinfect different hospital areas. Xenex’s patented pulsed xenon Full Spectrum UV room disinfection system eliminates harmful bacteria, viruses, and spores. The system is capable of killing C. diff, MRSA, VRE, and other multidrug-resistant organisms in a shorter time than other UV light devices.
UVD Robots – UV Disinfection Robot
Ultraviolet light is clinically proven as an effective disinfectant. It kills diseases, viruses, bacteria, and other types of microorganisms in the environment by breaking down their DNA-structure. Ultraviolet lamps suit small spaces, such as hospital rooms, as well as larger areas like airports and malls.
Danish startup UVD Robots produces UV-C disinfection robots for patient rooms, corridors, and other units in hospitals. The machines emit ultraviolet light that decontaminates surfaces by tearing apart strands of virus DNA. The robot scans the environment using LiDAR technology and creates a digital map. It then relies on Simultaneous Localization and Mapping (SLAM) to navigate and operate completely autonomously. The robot operates only when people are not around, using its sensors to detect motion and shutting the UV lights off if an individual is around.
XAG – Drone-Based Disinfection
Along with self-driving vehicles, drones also find innovative use cases in today’s lockdown situation. Agricultural drones are already in operation as autonomous precision spraying machines, as they are suitable for releasing disinfectants in public places. These drones are faster and therefore able to cover far more distances compared to traditional methods while keeping human operators out of potential exposure to both the virus and the disinfectant.
Chinese company XAG manufactures industrial Unmanned Aerial Systems (UAS) and established a special fund for a drone disinfection operation to fight COVID-19. The company uses its own agricultural drones to disperse disinfectants to improve public hygiene and reduce the risk of transmitting the virus through surface contact, also known as fomites.
Neolix – Autonomous Vehicles For Disinfecting
Autonomous vehicles have proven themselves extremely useful during this coronavirus outbreak, aside from their core offerings and applications. Their vehicles are capable of delivering medical supplies and food to residences, meals for overworked health workers on the front lines, and also distribute disinfectant in cities’ streets.
Neolix is a self-driving delivery vehicle startup from China that upgraded its vans in response to the coronavirus situation. Robotic vehicles drive around the city and atomize the disinfectants to help curb the spread of the virus. Neolix’s vans use a combination of sensors and high-definition maps in order to detect and avoid obstacles with a high degree of accuracy. Moreover, their battery system enables travel of up to 100 kilometers (62 mi) after a single charge.
The Robot market is booming!!!
Hospital-Disinfecting Robots: Xenex Sees Surge In Orders As COVID-19 Pandemic Escalates
As COVID-19 spreads across the world, hospitals have become ground zero for the virus.
It can be challenging for all the surfaces in a hospital room to be thoroughly disinfected when that room is being cleaned and prepared for the next patient. This poses obvious health risks, especially during a pandemic.
One company has developed a robot to help battle hospital-acquired infections (HAIs), and is now in a position to potentially help slow the spread of coronavirus within health care settings.
San Antonio-based Xenex makes full-spectrum UV Germ-Zapping Robots to eliminate harmful bacteria, viruses and spores that can cause HAIs in a patient environment. Ultimately, the company wants to become the new standard method for disinfection in health care facilities worldwide.
“The mission from the beginning was to reduce pain, suffering and needless deaths caused by hospital infections,” CEO Morris Miller told Crunchbase News.
As the pandemic has escalated, Xenex has seen “hundreds” of orders for its $125,000 disinfecting robot from all over the world, in particular Asia and Italy, according to Miller. In addition to new orders, the company has also seen a bump in purchases from its existing customers.
“Over the past month, our partners from all over the world, particularly in Asia, started ordering hundreds of robots. We’re working as hard as we can to fill all of those orders,” Miller said. “We’ve been working seven days a week for the last three to four weeks. In addition, we’ve seen an increase in orders from existing hospitals for robots for their emergency rooms.”
Xenex is also being asked for bids on quantities of robots “in the thousands,” he adde
After shipping a large number of robots to Italy, Irene Hahn, the company’s VP of sales wrote: “At any other time, we celebrate these wins; however, in light of what is happening in Italy, this one is different. …We are absolutely humbled to be in a position to help in the United States and across the globe.”
The recent increase in business follows a year in which Xenex turned the corner to profitability, according to Miller. Revenue percentage growth was up about 20 percent in 2019, but Miller projects growth will be anywhere from 400 to 600 percent in 2020.
Epidemiologists turned founders
Xenex was founded in Houston in 2009 by two Johns Hopkins-educated epidemiologists, Mark Stibich and Julie Stachowiak, and launched commercially in 2013. It has raised a known $86.4 million in venture funding over its lifetime, according to Crunchbase data, from investors such as Battery Ventures, Essex Woodlands Healthcare Partners Piper Jaffray Merchant Services and Tectonic Ventures. Its last known venture round, a $38 million raise, was announced in February 2017.
The $125,000 cost per robot may sound pricey, but the company estimates that figure translates to about $2 to $8 per room depending on the number of rooms it’s used in each day.
So far, Xenex’s robots have been deployed in more than 500 hospitals worldwide including The University of Texas MD Anderson Cancer Center, the Mayo Clinic Health System, Stanford, 55 Veterans Affairs (VA) facilities and 10 Department of Defense health care facilities. Worldwide, its robots are in the U.K., Europe, South America, Asia, Middle East and Africa. And those numbers are increasing daily, according to the company.
The robots are also now being used in other health care facilities such as surgery centers and skilled nursing facilities, as well as pharmaceutical clean rooms, a Los Angeles Police Department station and a Westin hotel in Houston.
Reducing infection
Xenex’s robot stands out from other similar devices because multiple outcome studies–published in nearly three dozen different peer-reviewed journals–have shown reductions of 53 percent to 100 percent of infections acquired in hospitals, according to Miller.
The company also claims its robot is the only pulsed xenon UV device of its kind, while dozens of other companies manufacture mercury UV devices. The robot, called LightStrike, also works significantly faster and more efficiently than other disinfecting methods, the company claims. Xenex says its high intensity, pulsed xenon UV (an environmentally friendly noble gas) is effective at rapidly (in 5 minutes) deactivating viruses and bacteria.
Xenex is on its fifth version of the robot currently on the market.
In 2011, MD Anderson published the first peer-reviewed study about Xenex’s technology, which showed that the LightStrike robot was able to get a room 22 times more disinfected than traditional cleaning methods. Miller estimates that number is even higher today as the technology behind the robot has evolved over time.
“We just keep making them better and different as we try to satisfy the hospitals’ needs,” he told me this morning.
Every time the robots are used, they report what’s happening to the cloud.
“They [Xenex’s customers] know who ran the robot, what room they ran it in, how long they ran the robot, how many times they ran it,” he said. “We don’t just sell the robots to hospitals, we give them a complete picture and essentially hold their hands every step of the way.”
VC perspective
Michael Brown, a general partner with Battery Ventures, told me in 2016 (when I previously covered the company) that he was drawn to Xenex and its innovative technology.
Brown’s father served as chairman of the board at St. David’s South Austin Medical Center so he had firsthand knowledge of the impact of hospital-acquired infections. When he heard about Xenex’s robot, Brown cold-called CEO Miller and “fell in love” with what the company was doing.
“We knew right away that this is a game-changing technology and something we wanted to be involved in,” Brown said.
Xenex offers LightStrike robots and the LightStrike Disinfection Pod, which is a portable containment unit that enables health care facilities to quickly disinfect high-touch mobile equipment that travel throughout a hospital such as wheelchairs and IV poles.
Xenex currently employs about 100 people but is already ramping up production staff to meet demand with plans to hire more than a dozen over the short term.
Disinfection Robots: A front-line assault on hospital-acquired infections?
COSTS AND REIMBURSEMENT
While disinfecting robot technology is
costly, there’s a direct correlation to
reducing infection risk for inpatients,
costs for treating HAIs, and patients’
length of stay. According to ECRI
Institute’s SELECTplus pricing database,
Bioquell’s Q-10 HPV system has an
average price of approximately $47,000,
the Xenex UV-C system costs
approximately $81,000, and the TRU-D
UV-C system costs $125,000 Service
contract costs should also be considered
as part of any lifecycle cost analysis.
The U.S. Centers for Medicare &
Medicaid Services (CMS) assesses
hospitals’ readmission payment
adjustments using three readmission
measures endorsed by the National
Quality Forum: heart attack, heart failure,
and pneumonia. CMS is finalizing its
proposal to add two new readmission
measures, which will be used to calculate
readmission penalties beginning in fiscal
year 2015: readmissions for hip/knee
arthroplasty and chronic obstructive
pulmonary disease. Disincentives, such as
lower reimbursement payments, are
expected to continue, and any higher costs
incurred due to HAIs may not be
reimbursed at all.
Introducing these technologies could
have large positive implications for
infection prevention practices and capital
and operational budgets. In addition,
administrators could see a return on
investment due to fewer staff-contracted
infections and loss of work time.
Implementing disinfection robotics might
not only improve patient health outcomes,
but also bring about significant savings and
cost avoidance for healthcare systems
With hospital supply chain, leasing often better option than buying
https://www.healthcarefinancenews.com/news/hospital-supply-chain-leasing-often-better-option-buying
You can lease, but don’t buy. That seems to be best advice for hospitals and health systems without piles of cash on hand, since they are better served leasing specialized or technical equipment rather than purchasing it.
While low interest rates might make it much more economical for hospitals to purchase, leasing often remains the better option, said David Lips, a healthcare transactions attorney with Hall Render Killian Heath & Lyman in Indianapolis.
When buying, you can get stuck with equipment that tends to become obsolete fairly quickly. Leasing, on the other hand, makes it easier to navigate regular equipment upgrades.
Lips said it makes more sense to rent or lease tools like copiers. After all, if the machine breaks down, the leasing company provides service. However, should a copier purchased by a facility require repair, the cost is covered under a separate service maintenance contract, "which may be fairly pricey," he said.
Healthcare consultant Elizabeth Knollmeyer is also partial to leasing, since it means hospitals can leave their money in their investments. If capital isn’t a problem, buying might be better, but that’s an accountant's decision, she said. Department heads should have input in the process, since they have direct knowledge of the durability and anticipated length of effectiveness of equipment used there, she said.
"If you're going to be stuck with a piece of equipment, since it's difficult to get rid of at the end of a 60 month term … then leasing's the best way to go," said Knollmeyer, who added she would purchase equipment with potentially longer shelf lives, like microscopes.
Question for the board?
Is PCTL selling or leasing the Annihilyzer Systems?
PCTL New York Connection Keeps Growing:
Oct 26, 2018 PCT Ltd enters into Master Services Agreement for Installation of Annihilyzer® Infection Control Systems in the Greater New York Area
Nov 1, 2018 PCT Ltd Secures Contract for 2 Annihilyzer® Hospital Infection Control Systems in Brooklyn Hospital
May 6 2019 PCT LTD Announces New Purchase Order as the Result of a Successful Trial of Annihilyzer® Infection Control Systems:
ACE Janitorial Supply Company (“ACE”), PCT Corp.’s distributor for the New York hospital and healthcare market, received a new purchase order for Morgan Stanley Presbyterian Children’s Hospital to continue using PCT Corp.’s patented Annihilyzer® Infection Control Systemfollowing a successful 60-day trial within the facility. Morgan Stanley Presbyterian Children’s Hospital is the fourth hospital to become a customer of PCT Corp’s.
Oct 7, 2019 PCT LTD ANNOUNCES ADDITIONAL HOSPITAL INSTALLATION OF
ANNIHILYZER® INFECTION CONTROL SYSTEM:
In coordination with its primary healthcare distributor, ACE Janitorial Services PCT Corp. installed the premier cabinet model of its Annihilyzer® Infection Control System this week at Mount Sinai South Nassau Medical Center located in Oceanside, NY.
Oct 31, 2019 PCT LTD Continues to Expand by Signing Long-Term Agreement with ACE:
ACE Janitorial, Inc., PCT Corp’s primary distributor in the northeastern United States healthcare market, inked a long-term (60-month) contract with PCT Corp. to continue providing the Annihilyzer® Infection Control System, as a significant extension of services provided last year, to a major hospital in New York City. These services include patented RFID bottle tracking and 24-hour remote monitoring for regulatory compliance.
Apr 14, 2020 PCT LTD ANNOUNCES RECEIPTS OF NEW PURCHASE ORDERS FOR ANNIHILYZER INFECTION CONTROL SYSTEMS IN NYC HOSPITALS:
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announces two new purchase orders for PCT Corp.’s Annihilyzer® Infection Control Systems.
May 8, 2020 PCT LTD CONTINUES ACCELERATED EXPANSION WITH NEW HOSPITAL INSTALLATIONS AND FLUID DISTRIBUTORS:
The company is also announcing a new hospital installation. Following up on an earlier release from April 14th, installation in a large NYC area hospital is expected to commence early next week through PCT’s primary healthcare distributor ACE Janitorial Services. Two additional installations are scheduled in NYC hospitals over the following weeks. Additional hospital installations of PCT Corp.’s Annihilyzer® Infection Control Systems are expected to continue throughout the end of the month and into the summer.
How many hospitals are in New York City?
62 acute care hospitals in New York City
What is the number one hospital in New York?
New York–Presbyterian Hospital, New York, N.Y.
What are the chances that some of these hospitals have shared their Anihilyzer experiences with other hospitals, some product or invited them over for a demostration.
New York you know has got a whole lot Of PCTL!!!
It is for for home use.
PCTL USA
From the March 9, 2020 CEOCFO Magazine Interview:
CEOCFO: There are so many new ideas and services for hospitals to consider. What is the key to getting a foot in the door?
Mr. Grieco: I would love to have the answer to this question! I have told people that I think I would rather sell a jet plane to the US government than try to get a product into a hospital again! It is very difficult, especially for a small company! There have been some people, and this is just gratifying on a personal level, who have recognized what we have accomplished. I have had people say that they never would have believed that we would have ever gotten into hospitals. The mere fact that the next hospital we will be going into was one of the ones that approached us is a major accomplishment, and I think you are going to be seeing more and more of that.
https://www.para-con.com/images/docs/PCTL03-10-20.pdf
Just how many hospitals or other organizations contacted PCTL?
When did the surge in calls start.
So from at least early March 2020 the phone is ringing off the hook at PCTL and by April 21, 2020 the company determines the need to produce at least 25 Annihilyzer Systems a month:
“We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
That gives them less than 3 months to get production up to produce 25 systems a month.
The BIG QUESTION is who are all these systems for?
Company currently has three new distributors and is expecting to add an additional three to four distributors within the next ten days. "Each one of these distributors is already in business," said Grieco. "What they are doing is shifting from using the harsh chemicals to using our product in their businesses," he continued, adding that hospitals have also expanded their use of the product in their facilities.
https://www.para-con.com/images/docs/PCTL04-21-20.pdf
PCT Europe Ltd (UK)
In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT’s unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the U.K. will also be introduced to PCT’s technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.
steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.This system is expected to enter clinical service early in May once the final series of biological tests of the PCT hospital disinfectant solution have been completed. Results of these tests have so far demonstrated that the PCT disinfectant has met or exceeded its ability to kill the range of pathogens previously achieved during EPA tests in the United States.
https://www.para-con.com/images/docs/PCTL04-16-20.pdf
PCTL China: Coming Summer 2020
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
Sodium Hypochlorit Spray, Hypochlorous Generator Acid Spray for Quick Home-made 84 Cleaning Electrolyzed Water, Only Salt+water is needed, no corrosion, Safe, Fast and Convenient
https://www.amazon.com/dp/B086KXCW7N/ref=sspa_dk_detail_0?psc=1&pd_rd_i=B086KXCW7N&pd_rd_w=0RAco&pf_rd_p=48d372c1-f7e1-4b8b-9d02-4bd86f5158c5&pd_rd_wg=GoXQl&pf_rd_r=2AGT2QQT8XT9ZYP9VMTZ&pd_rd_r=f493bc3f-9487-4e4d-91de-f9b06bc2b6d7&spLa=ZW5jcnlwdGVkUXVhbGlmaWVyPUE4RDlRWTlERE9SMUMmZW5jcnlwdGVkSWQ9QTAxNDY2NjUzMTdMMlRCVFBLRDRYJmVuY3J5cHRlZEFkSWQ9QTAzODE4ODhNMzBSMUZZOFhSOUomd2lkZ2V0TmFtZT1zcF9kZXRhaWwmYWN0aW9uPWNsaWNrUmVkaXJlY3QmZG9Ob3RMb2dDbGljaz10cnVl#customerReviews
States/Countries PCTL have operatiions/Clients (15)
Colorado
Florida
Illinois
Indiana
Michigan
Missouri
Nevada
New Jersey
New York
North Carolina
Oklahoma
South Carolina
Texas
Puerto Rico
United Kingdom
China (possible talks resume end of summer)
Was any place left off the list?
Why would they go STEALTH!!!
Well is looks like PCTL is in some serious discussions with someone as they have changed their playbook.
Nice move
Smart
Disruptive
PCTL USA
From the March 9, 2020 CEOCFO Magazine Interview:
CEOCFO: There are so many new ideas and services for hospitals to consider. What is the key to getting a foot in the door?
Mr. Grieco: I would love to have the answer to this question! I have told people that I think I would rather sell a jet plane to the US government than try to get a product into a hospital again! It is very difficult, especially for a small company! There have been some people, and this is just gratifying on a personal level, who have recognized what we have accomplished. I have had people say that they never would have believed that we would have ever gotten into hospitals. The mere fact that the next hospital we will be going into was one of the ones that approached us is a major accomplishment, and I think you are going to be seeing more and more of that.
https://www.para-con.com/images/docs/PCTL03-10-20.pdf
Just how many hospitals or other organizations contacted PCTL?
When did the surge in calls start.
So from at least early March 2020 the phone is ringing off the hook at PCTL and by April 21, 2020 the company determines the need to produce at least 25 Annihilyzer Systems a month:
“We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
That gives them less than 3 months to get production up to produce 25 systems a month.
The BIG QUESTION is who are all these systems for?
Company currently has three new distributors and is expecting to add an additional three to four distributors within the next ten days. "Each one of these distributors is already in business," said Grieco. "What they are doing is shifting from using the harsh chemicals to using our product in their businesses," he continued, adding that hospitals have also expanded their use of the product in their facilities.
https://www.para-con.com/images/docs/PCTL04-21-20.pdf
PCT Europe Ltd (UK)
In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT’s unique technology and system throughout the health services 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the U.K. will also be introduced to PCT’s technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.
steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021.This system is expected to enter clinical service early in May once the final series of biological tests of the PCT hospital disinfectant solution have been completed. Results of these tests have so far demonstrated that the PCT disinfectant has met or exceeded its ability to kill the range of pathogens previously achieved during EPA tests in the United States.
https://www.para-con.com/images/docs/PCTL04-16-20.pdf
PCTL China: Coming Summer 2020
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
Whole-room cleaning company sees dramatic rise in clients
https://cleanroomtechnology.com/news/article_page/Wholeroom_cleaning_company_sees_dramatic_rise_in_clients/163321
PCT has installed its Annihilyzer System at another New York City hospital. Annihilyzer Infection Control System is a whole-room cleaning and disinfecting system for hospital and healthcare facilities.
The CEO explains that the company has developed cleaning and disinfecting protocols, utilised with its patented RFID material tracking system, for the proper use of solutions and electrostatic applicators being used in every area of the facility.
“As a result of the capabilities and benefits of our products, many companies and municipalities across a variety of industries and geographic locations are engaging in intense discussions with PCT. We believe that this hospital will be the first of many installations during the coming months,” Grieco explained.
Grieco explained on the Stock Day Podcast that the company believes it has developed a unique type of disinfectant system based on hypochlorous acid. “The core technology, which is hypochlorous acid, has been around for many years, but it’s had what the market has perceived as drawbacks - not because of its efficacy, but because it’s not a product that lends itself to storage long-term.”
Greico emphasised that their disinfecting system has demonstrated its ability to destroy various bacteria and viruses, without the noxious and other adverse side effects found with conventional chlorine solutions.
Grieco added: “All of our hospital customers using our infection control system and disinfectant are utilising the systems as a front-line defence throughout their facilities, including in all public area such as restrooms, lobbies, waiting rooms, elevators, corridors, cafeterias, etc. all throughout the day and night and in the presence of patients, staff and visitors.”
Business
An article from March 2020, stated: “We expect to grow at the rate of two hospitals a month for the first part of this year and then to double that for the second half of the year. We have been dubbed a disruptive technology for hospitals. However, it does not have to be limited to hospitals. There are certainly other markets, such as assisted living facilities, schools, even companies and factories that could use this system to reduce sickness.”
Setting the 21st Century Paradigm
For infection prevention and EVS solutions for
HealthCare, Education, Transportation, and other
Institutions
Sanitis is devoted to offering the most effective and safest cutting edge products to help protect you and your environment from germs and provide cleaner facilities with less work. If we don't already have what you need, we'll source it for you. NO HARSH CHEMICALS HERE!
https://www.sanitisglobal.com/
Annihilyzer:
A New Disruptive Technology in the World of Hospital Disinfection
Defeating HAI's with science and technology, not toxic chemicals.
The Annihilyzer System is truly a cost-effective Green Seal Certified end-to-end total facility disinfection and cleaning system. This system generates both a hospital grade disinfectant and a very effective cleaning solution to cover virtually all of your cleaning and disinfection needs. These on-site generators produce stable electrochemically activated solutions, OSG 460D - Hospital Grade Disinfectant that is effective against C. diff, MRSA, and VRE, and an OSG 11-12 All Purpose Cleaner, and downtime for the process is only 15 - 20 minutes with no special preparation or precautions necessary.
The Annihilyzer System doesn't stop there, though. The icing on the cake is our state-of-the-art whole-room and handheld electrostatic sprayers that make quick work of completely disinfecting a room. Our 460D disinfectant can even be used to disinfect floors without leaving a haze or residue. We use a powerful non-synthetic disinfectant along with an automated electrostatic spray cart and/or electrostatic sprayers and patented RFID tracking technology that together are unmatched the industry to ensure proper and complete application.
With the Annihilyzer System, you can:
Save time and money by generating disinfectant and all-purpose cleaner on-site, on-demand
Eliminate the toughest bacteria, viruses, and fungi, including C. diff, C. auris, MRSA, VRE, blood-borne pathogens, and more.
Create 'industry best' protocols and 'push' them out to your cleaning staff in real-time with the Annihilist dashboard and mobile app
Generate reports that show when the areas were cleaned, who cleaned them, and what was done
Increase staff efficiency and effectiveness with process tracking, training, and accountability
The Annihilyzer System is being used in some of the leading hospitals in the country.
Contact us today for more information.
YOU GOOTA LOVE HOW PEOPLE ARE ADVERTISING!!!!
PCTL 2020 goals: (1/29/2020)
Use newly developed smaller scale systems to expand marketing to assisted living facilities and possibly schools. Begin marketing campaign at the of Q1.
2020 Q1: Installations of systems in 6 additional hospitals
Debt: Finalizing Consolidation of debt through equity investment
Equity: Completion of negotiations with a number of potential sources of equity investment
Further discussions with possible industry partners
General Growth: Continue double digit growth with transition to cash flow positive and operating profitability during the second half of 2020
Improved Communication: Utilizing Social Media
Creation of new domain for our healthcare-specific market (www.pctcorphealth.com) and actively using The Chesapeake Group and www.para-con.com for investor relations, in addition to developing www.pctcorpoilandgas.com website(s) and www.pctcorpag.com website(s)
More consistent communication strategy via updates on website, shareholders letters, conference calls, interviews and press releases
PCTL is in a great position to disrupt the market share of contracts for Infection Control Systems with Healthcare and other industries.
Why did they focus on Healthcare first?
Hospital Disinfectant Products Market to Expand at Growth Rate of ~ 5.3% CAGR from 2018 to 2026 to Reach US$ 17.1 Billion through 2026:
https://www.prnewswire.com/news-releases/hospital-disinfectant-products-market-to-expand-at-growth-rate-of--5-3-cagr-from-2018-to-2026-to-reach-us-17-1-bn-through-2026-transparency-market-research-300999388.html
PCTL is a small player and is limited by their size and available financing. I'm sure they are well aware of this and are aggressively working to find a deep pocket investor(s) or possible partnership.
PCTL has the best solution to a multi-billion dollar problem will it be an investor or a partnership to help solve it.
Maybe it will be one these major players:
Key companies in the Hospital Disinfectant Products market include The Procter & Gamble Company, Colgate-Palmolive Company, Baxter International Inc, Kimberly-Clark Corporation, Getinge AB, and Georgia-Pacific LLC
Multi-Billion dollar problem:
Hospitals & Healthcare:
The Problem:
Preventing Microbial Infections
Many billions of dollars a year are spent by individuals, organizations and the health care system to treat people who get infectious diseases caused by microbes including bacteria, viruses and fungi. With the advent of adaptive and ever more dangerous microorganisms called “super bugs”, the danger of acquiring life-threatening infections is real and growing. This danger affects everyone anytime they are in space where people gather, any microbe contaminating that space is a possible source of infection. With American’s spending 20 or more hours a day indoors, much of it in spaces that are not cleaned and sanitized/ disinfected properly, the threat of infection is constant, growing and dangerous, particularly to our vulnerable populations of the very young, elderly and infirm.
Infectious diseases were associated with an economic burden of over $120 billion in the U.S. in 2014. Antibiotic resistant infections cost Americans $20 billion in direct medical costs and $35 billion in lost productivity in 2014. A particularly acute problem is Hospital Acquired Infections (HAIs) which are increasingly hard to kill or treat effectively. As a result, doctors struggle to contain, fight and cure increasingly antibiotic resistant infections such as MRSA, and C. Diff. The more antibiotics, medicines, pesticides and disinfectants are used to kill them, the quicker the microorganisms adapt, becoming ever stronger and more drug-resistant. Researchers estimate that, if the U.S. could reduce the number of hospital-acquired infections by 20%, healthcare providers would save nearly $7 billion per year. Insurance companies are beginning to deny coverage for treatment of HAIs, forcing hospitals to self-insure. This will create an immense financial and risk-management burden on hospitals, long-term medical, rehabilitation and assisted living facilities.
https://pctcorphealth.com/
The Solution:
Overcoming the problem of microbial contamination and infectious disease can be straightforward. It requires proper products, equipment, protocols, education, and training for comprehensive and reliable cleaning, sanitizing and disinfecting solutions. PCT Corp. offers these with its comprehensive “Green Cleaning” and Infection Control Systems. Infectious microbes cannot develop resistance to the cleaning and sanitizing products PCT Corp. uses and they are much less toxic to humans or pets than traditional agents such as bleach and ammonia.
The products are used through a commercially-ready, patented, integrated product and technology solution for total facility cleaning and sanitizing. This system and solution, The PCT Annihilyzer® Infection Control System, was specifically designed for use in hospitals, assisted-living and nursing homes and other large facilities. In various configurations, the solution system can be deployed in urgent care centers, medical, dental and veterinary practices and other health care facilities. A complete and custom turn-key cleaning, sanitizing and disinfection program solution can be provided to each facility. It is also adaptable to deployment in schools, prisons, hotels and many other facilities.
PCT has launched a major marketing and sales effort in the hospital facilities market and The PCT Annihilyzer® System has now been deployed in several hospitals in the eastern U.S.
Learn more about The Annihilyzer® System
https://www.para-con.com/products.php#annihilyzer
Agriculture
In the agriculture world, through USDA grants and multiple studies by universities around the world, Hypochlorous acid solutions have been tested and proven effective against yield-reducing crop pathogens in post-harvest applications to include sanitizing at point of harvest, point of packing and points of sale.
We are hoping to help stop these crop-devastating pathogens with our hypochlorous solutions that are known to be environmentally responsible and designed to improve and maintain crop yields, to produce a healthier overall harvest.
Oil and Gas
Waste Water Treatment
Our system helps to decontaminate “frac” water for reuse in the fracking process, saving the industry millions of dollars and preserving the world’s water supply. Some of the many benefits of our system/process include: Elimination of highly toxic chemicals currently used for decontamination, reduced negative environmental impact, reduced recovery costs and potentially opening new areas for oil and gas retrieval.
Turning “Sour” Crude Oil to “Sweet"
In other areas in the gas and oil industry that presents a challenge is in treating existing wells for the presence of H2S of hydrogen sulfide. H2S is a large and growing problem in the industry, due to its continued introduction of bacteria in the fracking process. H2S causes increased production costs. Our solutions reduce those costs and reduce the environmental impact.
Other
Hotel and Tourism
Similar to the healthcare environment, the hotel and tourism industry (i.e resorts, airports, cruise ships, etc.) are subject to communicable diseases. In the healthcare market, they are referred to as Hospital-Acquired Infections/Healthcare-Associated Infections (HAIs) and in the hotel and tourism industry, they are known as Community-Acquired Infections. With as many different people traveling through these areas, from all sorts of countries and carrying various types of ailments or pathogens with them, consider the potential for an uncontrollable spread of these germs.
Outbreaks are typically caused by lack of proper processes and/or a failing product. Our ECA technology is designed to help anyone in the industry to get a grip on the issue and succeed at their main goal: providing an awesome experience for their guests.
Food Service/Production
Our sanitizer strength solution meets the requirement of the FDA and USDA, to be a non-rinse sanitizing agent. In the world of dealing with food, why not use a product that actually kills food-borne pathogens - without containing any toxic chemicals that would harm the quality of the product?
Whether you’re dealing with meat, poultry or just need to maintain a facility’s defense against Salmonella/E. coli, contact us about using our solutions.
Learn more at Survivalyte.com
http://survivalyte.com
Various Technological Advancements are set to Grow the Global Biotechnology Market
https://www.biospace.com/article/releases/various-technological-advancements-are-set-to-grow-the-global-biotechnology-market/
PCTL has made tremendous progess from significant a company milestone reached just 18 months ago (November 2018):
The company announced that they have, "reached significant company milestones through its wholly-owned operating subsidiary Paradigm Convergence Technologies Corporation (PCT Corp.). PCT Corp. has successfully completed two Beta Site trials and installations at major healthcare facilities, which have been converted into long-term agreements for its Annihilyzer® Infection Control Systems. PCT Corp. has also established agreements with several Manufacturing Representatives for geographical territories in the healthcare market. With these milestones achieved, PCT Corp. has commenced the full-scale marketing launch of its hospital infection control systems.
PCTL has seen the an explosive growth in sales and services in the last quarter and has deployed Annihilyzer Infection Control Systems in at least 13 hospitals and have expanded operations to at least 15 states/countries.
“We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, delivering at least 25 systems a month,” said Grieco.
We had to turn down business in a "Major Market" due to the Pandemic Crisis:
Grieco then addressed rumors that the Company is expanding into China. Grieco shared that the Company signed an MOU in January of 2020, which required the Company to deliver systems. “When the pandemic broke, we took that out of the equation,” said Grieco. “What we have done is tabled any discussions until late summer,” he continued. “I don’t feel that we should be shipping any systems anywhere as long as we need them here in the United States.”
PCTL was around before the Pandemic
PCTL benefited from the Pandemic
PCTL will be around after the Pandemic
You are asking some questions that only the company can answer and not anyone on this message board.
So if you really want an answer call the company because all you going to get here is people opinions.
PCTL looked into getting on a Canadian Exchange.
Daily trading is just the MM making a market.
When news come good/bad then we will see some serious price action.
From the March 9, 2020 CEOCFO Magazine Interview:
CEOCFO: There are so many new ideas and services for hospitals to consider. What is the key to getting a foot in the door?
Mr. Grieco: I would love to have the answer to this question! I have told people that I think I would rather sell a jet plane to the US government than try to get a product into a hospital again! It is very difficult, especially for a small company! There have been some people, and this is just gratifying on a personal level, who have recognized what we have accomplished. I have had people say that they never would have believed that we would have ever gotten into hospitals. The mere fact that the next hospital we will be going into was one of the ones that approached us is a major accomplishment, and I think you are going to be seeing more and more of that.
https://www.para-con.com/images/docs/PCTL03-10-20.pdf
Just how many hospitals or other organizations contacted PCTL?
When did the surge in calls start.
So from at least early March 2020 the phone is ringing off the hook at PCTL and by April 21, 2020 the company determines the need to produce at least 25 Annihilyzer Systems a month:
“We are in a position as a company on a cash flow basis to cover the burn-rate,” said Grieco. “So, we finally have free available cash flow,” he added. “We have to expand very rapidly. We see a need, starting in July, to start delivering at least 25 systems a month,” said Grieco.
https://www.para-con.com/images/docs/PCTL04-21-20.pdf